Schedule 13G ownership disclosure
KIORA PHARMACEUTICALS INC
Common Shares · CUSIP: 49721T101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rosalind Advisors, Inc.
Shares: 715,231.00 · Class: 9.9%
- SALAMON STEVEN A J
Shares: 715,231.00 · Class: 9.9%
- Aharon Gil
Shares: 715,231.00 · Class: 9.9%
- Rosalind Master Fund L.P.
Shares: 715,231.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001622627-25-000006
- Form type
- SCHEDULE 13G/A
- Filer
- KIORA PHARMACEUTICALS INC
- CIK
- CIK 1372514
- Filed
- Feb 10, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership